Editorial
Published on 08 Aug 2025
Editorial: Immunity in aging and age-related diseases and dysfunctions
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1673414
- 262 views
Type at least 3 characters
1,216 articles
Original Research
Accepted on 05 Aug 2025
Mechanism of IFITM1 regulating epidural scar hyperplasia after laminectomy through SMAD3/CBR4 pathway
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1628970
- 102 views
Editorial
Accepted on 04 Aug 2025
Editorial: Interactions Between Autophagy and Immune Response: Cell Communication and Disease Implications
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1676537
- 222 views
Review
Accepted on 04 Aug 2025
Leukocyte recruitment in flavivirus-induced encephalitis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1650903
Original Research
Accepted on 01 Aug 2025
Combination of αCD4 Antibody and Retinal Antigen Injection Induces Long-Term Disease Control in Autoimmune Uveitis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1636901
- 461 views
Mini Review
Accepted on 28 Jul 2025
Mini-review: Serum immunoglobulins and MASLD
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1655560
- 162 views
Original Research
Published on 28 Jul 2025
Impact of high hydrostatic pressure on the cytokine profile and head and neck cancer cell behavior: implications for oncological safety
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1581014
- 864 views
Original Research
Accepted on 24 Jul 2025
NUPA10hd-immortalized and genetically engineered progenitors allow studying dendritic cell immune functions
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1658429
- 146 views
Editorial
Published on 24 Jul 2025
Editorial: The role of TGF-beta superfamily members in immune homeostasis and disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1663433
- 547 views
Editorial
Published on 23 Jul 2025
Editorial: Organ crosstalk and other responses to an activated immune system in trauma and disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1651022
- 523 views
Correction
Published on 23 Jul 2025
Correction: Endogenous SLPI contributes to the regulation of inflammatory responses in peritoneal macrophages by modulating MMP-9 production
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1645241
- 421 views
Original Research
Published on 23 Jul 2025
Evaluation of the levels of interleukins IL-4, IL-13, IL-5, IL-10 and IL-33 in atopic dermatitis patients with and without dupilumab therapy
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604883
- 843 views
Original Research
Published on 23 Jul 2025
Metrnl/Meteorin-like/IL-41, a novel regulator of bone metabolism and disease activity in ankylosing spondylitis: based on multi-omics analysis
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1595181
- 785 views
Original Research
Accepted on 18 Jul 2025
Elevated NK and T cell associated cytokines in plasma associate with serological response to influenza vaccination
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1662942
- 244 views
Review
Published on 10 Jul 2025
Mechanistic insights into Nrf2-driven pathogenesis and therapeutic targeting in spinal cord injury
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1574834
- 1,130 views
Mini Review
Published on 08 Jul 2025
Dichotomous roles of IL-36 and IL-38 in cardiovascular disease
in Cytokines and Soluble Mediators in Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2025.1642116
- 891 views